T651-0260 Screening compound: N-{(1R,5S)-8-[(3,5-DIMETHYL-4-ISOXAZOLYL)SULFONYL]-8-AZABICYCLO[3.2.1]OCT-3-YL}-5-METHYL-2-PYRAZINECARBOXAMIDE

T651-0260 Screening compound: N-{(1R,5S)-8-[(3,5-DIMETHYL-4-ISOXAZOLYL)SULFONYL]-8-AZABICYCLO[3.2.1]OCT-3-YL}-5-METHYL-2-PYRAZINECARBOXAMIDE
T651-0260 Screening compound: N-{(1R,5S)-8-[(3,5-DIMETHYL-4-ISOXAZOLYL)SULFONYL]-8-AZABICYCLO[3.2.1]OCT-3-YL}-5-METHYL-2-PYRAZINECARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound T651-0260
N-{(1R,5S)-8-[(3,5-DIMETHYL-4-ISOXAZOLYL)SULFONYL]-8-AZABICYCLO[3.2.1]OCT-3-YL}-5-METHYL-2-PYRAZINECARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T651-0260

Molecular Formula

C18H23N5O4S (C18 H23 N5 O4 S)

Compound Name

N-{(1R,5S)-8-[(3,5-DIMETHYL-4-ISOXAZOLYL)SULFONYL]-8-AZABICYCLO[3.2.1]OCT-3-YL}-5-METHYL-2-PYRAZINECARBOXAMIDE

IUPAC name

n/a

SMILES

Cc1noc(C)c1S(N([C@H](CC1)C2)[C@@H]1CC2NC(c1ncc(C)nc1)=O)(=O)=O

InChI

InChI=1S/C18H23N5O4S/c1-10-8-20-16(9-19-10)18(24)21-13-6-14-4-5-15(7-13)23(14)28(25,26)17-11(2)22-27-12(17)3/h8-9,13-15H,4-7H2,1-3H3,(H,21,24)/t13?,14-,15+

InChI Key

ZQHPJUFWPAVJOF-GOOCMWNKSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

405.48

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

-0.055

Distribution Coefficient, logD

-0.055

Water Solubility, LogSw

-2.12

Polar Surface Area

96.441

Acid Dissociation Constant (pKa)

12.92

Base Dissociation Constant (pKb)

-0.08

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

55.60

T651-0260 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Bromodomain Modulators Library (5801 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T651-0260 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T651-0260?
Check Price and Availability of T651-0260, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T651-0260 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T651-0260
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T651-0260
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T651-0260 available by request